Most mutations in genes constituting the RAS–RAF–MEK–ERK signaling pathway are reported in mucinous adenocarcinomas of the appendix (nine genes), followed by appendiceal goblet cell adenocarcinomas and well-differentiated neuroendocrine tumors of the appendix, with six genes each. Here, RAF1 is linked to mucinous adenocarcinoma of the appendix.